Elevance Health, Inc. (FRA:A58)

Germany flag Germany · Delayed Price · Currency is EUR
295.70
+3.40 (1.16%)
At close: Feb 20, 2026
Market Cap64.24B -28.2%
Revenue (ttm)169.60B +12.6%
Net Income4.82B -5.3%
EPS21.47 -1.8%
Shares Outn/a
PE Ratio13.32
Forward PE13.36
Dividend6.00 (2.03%)
Ex-Dividend DateDec 5, 2025
Volumen/a
Average Volume2
Open295.70
Previous Close292.30
Day's Range295.70 - 295.70
52-Week Range235.80 - 411.00
Betan/a
RSI52.80
Earnings DateJan 28, 2026

About Elevance Health

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]

Industry Hospital and Medical Service Plans
Founded 2001
Employees 97,100
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol A58
Full Company Profile

Financial Performance

In 2025, Elevance Health's revenue was $199.13 billion, an increase of 12.62% compared to the previous year's $176.81 billion. Earnings were $5.66 billion, a decrease of -5.32%.

Financial numbers in USD Financial Statements